Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

0.3973
Delayed Data
As of 2:44pm ET
 -0.0022 / -0.55%
Today’s Change
0.32
Today|||52-Week Range
1.99
-59.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$24.7M

Company Description

Apricus Biosciences, Inc. is a pharmaceutical company focus on the development and commercialization of products and product candidates in the areas of specialty urology and rheumatology. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.

Contact Information

Apricus Biosciences, Inc.
11975 El Camino Real
San Diego California 92130
P:(858) 222-8041
Investor Relations:

Employees

Shareholders

Individual stakeholders7.05%
Mutual fund holders3.22%
Other institutional26.55%

Top Executives

Richard W. PascoeChief Executive Officer, Secretary & Director
Catherine BovenizerChief Accounting Officer & Vice President-Finance
Neil C. MortonChief Business Officer & Senior Vice President
Brian T. DorseyChief Development Officer & Senior Vice President